| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 16.62B | 15.93B | 15.12B | 13.06B | 9.85B | 7.52B |
| Gross Profit | 5.82B | 7.06B | 6.58B | 3.52B | 977.79M | 1.18B |
| EBITDA | -5.39B | -3.69B | 3.23B | 1.44B | 1.23B | 538.84M |
| Net Income | -7.61B | -5.38B | -280.18M | -2.68B | -3.05B | -2.54B |
Balance Sheet | ||||||
| Total Assets | 14.61B | 21.53B | 27.28B | 25.24B | 27.96B | 29.26B |
| Cash, Cash Equivalents and Short-Term Investments | 6.29B | 10.81B | 10.92B | 11.88B | 15.24B | 16.66B |
| Total Debt | 902.25M | 1.03B | 212.03M | 332.34M | 0.00 | 0.00 |
| Total Liabilities | 7.20B | 11.48B | 4.67B | 3.18B | 2.57B | 1.94B |
| Stockholders Equity | 7.42B | 10.05B | 22.62B | 22.06B | 25.38B | 27.31B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -420.94M | -1.18B | -1.84B | -2.07B | -2.37B |
| Operating Cash Flow | 0.00 | 1.13B | 2.24B | 953.69M | 641.94M | 880.74M |
| Investing Cash Flow | 0.00 | -1.07B | -3.72B | -2.92B | -2.35B | -3.20B |
| Financing Cash Flow | 0.00 | -50.88M | -27.14M | -1.32B | -36.95M | -20.42M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥33.07B | 21.70 | ― | 0.73% | 17.86% | 21.52% | |
76 Outperform | ¥27.37B | 26.51 | ― | 1.50% | 7.83% | 49.73% | |
74 Outperform | ¥29.93B | 15.13 | ― | 4.36% | 12.32% | 10.42% | |
74 Outperform | ¥30.24B | 12.57 | ― | 2.93% | 2.11% | 5.55% | |
72 Outperform | ¥41.11B | 17.64 | ― | 2.45% | 19.04% | 30.67% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
46 Neutral | ¥25.08B | -3.70 | ― | ― | 25.89% | -285.21% |
ACCESS CO., LTD. announced that its U.S. subsidiary IP Infusion Inc. is facing a payment delay under a three-year, USD 70 million license and service contract for its OcNOS network operating system with UAE-based Evollabs Tech FZ-LLC. Of the USD 30 million scheduled to be paid by the end of 2025, USD 20 million remains unpaid as of January 5, 2026, and the company is currently confirming the payment status with Evollabs while continuing collection efforts, noting that it will provide further updates if any additional disclosure-worthy events occur.
The most recent analyst rating on (JP:4813) stock is a Hold with a Yen563.00 price target. To see the full list of analyst forecasts on Access Co., Ltd. stock, see the JP:4813 Stock Forecast page.
ACCESS CO., LTD. announced that it will again postpone the timely disclosure of its internal control improvement plans and status report, shifting the planned release from late December 2025 to January 2026. The delay follows the Tokyo Stock Exchange’s earlier designation of the company as a Security on Special Alert and the imposition of a listing agreement penalty, which triggered a series of remedial steps including an investigation by a Special Investigation Committee, formulation of recurrence-prevention policies, and submission of draft plans to Japan Exchange Regulation. While much of the remediation process has been implemented or partially implemented, the company says it needs more time to finalize the improvement plans, and it has apologized to shareholders, investors and business partners for the added uncertainty, indicating that the eventual disclosure will be key to assessing the progress of its governance and internal control reforms.
The most recent analyst rating on (JP:4813) stock is a Hold with a Yen563.00 price target. To see the full list of analyst forecasts on Access Co., Ltd. stock, see the JP:4813 Stock Forecast page.
ACCESS CO., LTD. announced that its U.S. subsidiary IP Infusion has signed a three-year license and service agreement worth USD 70 million with UAE-based Evollabs Tech for the provision of its OcNOS network operating system, associated maintenance and support, and development of additional functions. The deal positions OcNOS as a key software platform for white-box hardware that Evollabs plans to sell mainly in the Middle East, reflecting rising demand for scalable, cost-efficient data center and GPU networking solutions. IP Infusion has so far received USD 10 million of the USD 30 million it expects to collect by the end of 2025, and while some payments are overdue, the project is described as progressing smoothly, with the company pledging timely updates on collections and noting that the transaction, already factored into its January 2026 earnings forecast, could still affect consolidated results depending on final accounting treatment.
The most recent analyst rating on (JP:4813) stock is a Sell with a Yen483.00 price target. To see the full list of analyst forecasts on Access Co., Ltd. stock, see the JP:4813 Stock Forecast page.
ACCESS CO., LTD. announced a foreign exchange gain of 104 million yen and an impairment loss of 68 million yen for the third quarter of the fiscal year ending January 2026. These financial adjustments have been incorporated into the company’s consolidated financial results and forecasts, with no changes to the previously announced business performance forecast due to the inherent uncertainties in foreign exchange rate fluctuations.
The most recent analyst rating on (JP:4813) stock is a Sell with a Yen483.00 price target. To see the full list of analyst forecasts on Access Co., Ltd. stock, see the JP:4813 Stock Forecast page.
Access Co., Ltd. reported its consolidated financial results for the nine months ended October 31, 2025, showing a significant increase in net sales by 29.5% compared to the previous year. However, the company faced substantial losses in operating and ordinary profit, with a notable decline in profit attributable to owners of the parent. The financial position indicates a decrease in total assets and net assets, with an equity-to-asset ratio of 54.4%. The company has not announced any dividends for the fiscal year ending January 31, 2026, and there are no revisions to the financial forecast.
The most recent analyst rating on (JP:4813) stock is a Sell with a Yen483.00 price target. To see the full list of analyst forecasts on Access Co., Ltd. stock, see the JP:4813 Stock Forecast page.
Access Co., Ltd. has announced a delay in the disclosure of its improvement plans and status report, initially scheduled for late November 2025, now postponed to December 2025. This postponement is due to ongoing deliberations on formulating these plans, following a designation by the Tokyo Stock Exchange as a Security on Special Alert, necessitating improvements in the company’s internal controls.
The most recent analyst rating on (JP:4813) stock is a Hold with a Yen579.00 price target. To see the full list of analyst forecasts on Access Co., Ltd. stock, see the JP:4813 Stock Forecast page.